Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sabine Kinloch-de Loes
Anna-Maria Geretti

Showing results (1-10 of 165) with videos related to

Pageof 17
Sort By:
Current Opinion in HIV and AIDS|April 18, 2009
Therapeutic immunization in HIV infectionBrigitte Autran, Sabine Kinloch-de Loes, Christine Katlama
Current Opinion in HIV and AIDS|April 18, 2009
Treatment of acute HIV-1 infection: are we getting there?Cristina Cellerai, Susan J Little, Sabine Kinloch-de Loes
Current Opinion in Infectious Diseases|June 18, 2009
Autoimmunity and HIVRichard Stratton, Gabrielle Slapak, Tabitha Mahungu, et al.
Plos One|April 13, 2011
Early and prolonged antiretroviral therapy is associated with an HIV-1-specific T-cell profile comparable to that of long-term non-progressorsCristina Cellerai, Alexandre Harari, Hans Stauss, et al.
Clinical Medicine (London, England)|October 3, 2015
Management of cardiovascular conditions in a cohort of patients with HIV: experience from a joint HIV/cardiology clinicSudheer Koganti, Sabine Kinloch-de Loes, Samantha Hutchinson, et al.
Journal of HIV Therapy|May 8, 2003
A virological perspective on resistance in highly treatment-experienced patientsAnna-Maria Geretti
Journal of HIV Therapy|July 9, 2004
Essential benefits of nucleoside analogue regimens in failing therapyAnna Maria Geretti
Current Opinion in Infectious Diseases|January 2, 2007
Epidemiology of antiretroviral drug resistance in drug-naïve personsAnna Maria Geretti
The Journal of Antimicrobial Chemotherapy|June 24, 2008
Shifting paradigms: the resistance profile of etravirineAnna Maria Geretti
Journal of HIV Therapy|June 14, 2005
The clinical significance of viral fitnessAnna Maria Geretti
Pageof 17

Showing results (1-10 of 165) with videos related to

Sort By:
Pageof 17
Current Opinion in HIV and AIDS|April 18, 2009
Therapeutic immunization in HIV infectionBrigitte Autran, Sabine Kinloch-de Loes, Christine Katlama
Current Opinion in HIV and AIDS|April 18, 2009
Treatment of acute HIV-1 infection: are we getting there?Cristina Cellerai, Susan J Little, Sabine Kinloch-de Loes
Current Opinion in Infectious Diseases|June 18, 2009
Autoimmunity and HIVRichard Stratton, Gabrielle Slapak, Tabitha Mahungu, et al.
Plos One|April 13, 2011
Early and prolonged antiretroviral therapy is associated with an HIV-1-specific T-cell profile comparable to that of long-term non-progressorsCristina Cellerai, Alexandre Harari, Hans Stauss, et al.
Clinical Medicine (London, England)|October 3, 2015
Management of cardiovascular conditions in a cohort of patients with HIV: experience from a joint HIV/cardiology clinicSudheer Koganti, Sabine Kinloch-de Loes, Samantha Hutchinson, et al.
Journal of HIV Therapy|May 8, 2003
A virological perspective on resistance in highly treatment-experienced patientsAnna-Maria Geretti
Journal of HIV Therapy|July 9, 2004
Essential benefits of nucleoside analogue regimens in failing therapyAnna Maria Geretti
Current Opinion in Infectious Diseases|January 2, 2007
Epidemiology of antiretroviral drug resistance in drug-naïve personsAnna Maria Geretti
The Journal of Antimicrobial Chemotherapy|June 24, 2008
Shifting paradigms: the resistance profile of etravirineAnna Maria Geretti
Journal of HIV Therapy|June 14, 2005
The clinical significance of viral fitnessAnna Maria Geretti
Pageof 17